维普期刊资源整合服务平台（V6.5）

186篇 您的检索式：作者名="Smit EF"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	MEK114653 :a randomized,multicenter,phase H study to assess efficacy andsafety of trametinib ( T) compared with docetaxel ( D ) in K-Ras-mutant advanced non-small cell lung cancer( NSCLC) 显示文摘	Blumenschein GR Smit EF Planchard D	2013	J ClinOncol2013，31，15：	1
2	Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-a phase Ⅲ study of the european organization for the research and treatment of cancer lung cancer cooperative group 显示文摘	Postmus PE Hanny HR Smit EF	2000	Clin Oncol2000，18，19：	1
3	Multidrug resist- ance related molecules in human and murine lung 显示文摘	Scheffer GL Pijnenborg AC Smit EF	2002	J Clin Pathol2002，55，5：	1
4	Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial 显示文摘	van Tinteren H Hoekstra OS Smit EF	2002	Lancet2002，359，：	1
5	Outcome of bronchial carcinoma in situ显示文摘	Venmans BJ van Boxem TJ Smit EF	2000	Chest2000，117，6：	1
6	Prognostic relevance of response evaluation using ^18F-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer 显示文摘	Hoekstra C J Stroobants SG Smit EF	2005	J Clin Oncol2005，23，33：	1
7	Dose-finding and Pharmascokinetic study of cisplatin,gemcitabine,and SU5416 in patients with solid tumors显示文摘	Kuenen BC Rosen L Smit EF	2002	J Clin Oncol2002，20，4：	1
8	Response?speed,? contingent negative variation?and?P300?in Alzheimer's disease and MCI显示文摘	van Deursen JA ?Vuurman EF ?Smits LL	2009	69(3): 592-5992009，69，3：	1
9	Three- arm randomized study of two cisplatin-based regimens and paclitaxel plus gemeitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975 显示文摘	SMIT EF VAN MEERBEECK JP LIANES P	2003	J Clin Oncol2003，21，21：	1
10	Phase Ⅲ study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer显示文摘	Soeinski MA Smit EF Lorigan P	2009	Clin Oncol2009，27，28：	1
11	Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer 显示文摘	Soeinski MA Smit EF Lorigan P	2009	J ClinOncol2009，27，28：	1
12	Prognostic relevance of response evaluation using-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer显示文摘	Hoekstra C J Stroobants SG Smit EF	2005	J Clin Oncol2005，23，33：	1
13	Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage Ⅲ AN2 non-small cell lung cancer:a phase Ⅱ study of the European Organization for Research Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)显示文摘	Van Zandwijk N Smit EF Kramer GW	2000	J Clin Oncol2000，18，：	1
14	Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors 显示文摘	Rosen L Smit EF	2002	J Clin Oncol2002，20，6：	1
15	Phage I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small cell lung cancer 显示文摘	Lind JS Lagerwaard FJ Smit EF	2009	Int J Radiat Oneol Biol Phys2009，113，9：	1
16	Gemcitabine and cisplatin as induction regimen for patients with biopsy proven Stage Ⅲ A N2 non-small-cell lung cancer:a phase Ⅱ study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)显示文摘	Van Zandwijk Smit EF Kramer GW	2000	J Clin Oncol2000，18，：	1
17	Prognostic relevance of response evaluation using lSF-2-fluoro-2deoxy-d-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer显示文摘	Hoekstra CJ Stroobants SG Smit EF	2005	J Clin Oncol2005，23，33：	1
18	A phase Ⅱ study of oral etoposide in elderly patients with small cell lung cancer显示文摘	Smit EF Carney DN Harford P	1989	Thorax1989，44，8：	1
19	Side -effects of long -term ad- ministration of erlotinib in patients with non - small cell lung cancer 显示文摘	Becker A van Wijk A Smit EF et at	2010	J Thorac Onco12010，5，9：	1
20	Dual inhibition of EGFR with afatinib and eetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutations显示文摘	Janjigian YY Smit EF Groen H J	2014	Cancer Discov2014，4，9：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示